doc_id	relation_id	relation_name	gene_words	hpoterm_words	words	sentences_before	sentences_after	expectation	gene_expectation	hpoterm_expectation	features	weights
SCPDFS_368.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_368.pdf_382_382_2_2_6_6	p53/HP:0100242|Sarcoma	{2}	{6}	{Mechanisms,of,p53,loss,in,human,sarcomas,.}	{"30 , 962-968 .","Mulligan , L.M. , Matlashewski , G.J. , Scrable , H.J. , and Cavenee , W.K. ( 1990 ) ."}	{"Proc .","Natl. Acad ."}	0.772	0.15	0.938	{DEP_PATH_POS_[nn-prep_of|NN@prep_in],"WORD_SEQ_[loss in human]",POS_SEQ_[NN_IN_JJ],DEP_PATH_[nn-prep_of|loss@prep_in]}	{0.597549,0.483569,0.199886,0}
SCPDFS_46864.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_46864.pdf_124_124_16_16_20_22	POLG/HP:0000590|Progressive external ophthalmoplegia	{16}	{20,21,22}	{Science,289,",",782-785,8,Van,Goethem,",",G.,et,al.,(,2001,),Mutation,of,POLG,is,associated,with,progressive,external,ophthalmoplegia,characterized,by,mtDNA,deletions,.}	{"Genet .","28 , 223-231 7 Kaukonen , J. et al. ( 2000 ) Role of adenine nucleotide translocator 1 in mtDNA maintenance ."}	{"Nat .","Genet ."}	0.708	0.074	1	{"WORD_SEQ_[be associate with]",POS_SEQ_[VBZ_VBN_IN],DEP_PATH_[prep_of-rcmod|(-appos|G.-nsubjpass|Science@prep_with],VERB_DEP_PATH_POS_[associate]_[prep_of-rcmod|FW-appos|NNP-nsubjpass|NNP@]_[prep_with@],DEP_PATH_POS_[prep_of-rcmod|FW-appos|NNP-nsubjpass|NNP@prep_with],VERB_DEP_PATH_[associate]_[prep_of-rcmod|(-appos|G.-nsubjpass|Science@]_[prep_with@]}	{1.63926,-0.778523,0,0,0,0}
journal.pone.0001870.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0001870.pdf_615_615_30_30_33_37	HNF1A/HP:0004904|Maturity-onset diabetes of the young	{30}	{33,34,37}	{Ellard,S,",",Thomas,K,",",Edghill,EL,",",Owens,IVI,",",Ambye,L,",",et,al.,(,2007,),Partial,and,whole,gene,deletion,mutations,of,the,GCK,and,HNF1A,genes,in,maturity-onset,diabetes,of,the,young,.}	{"BiochemJ 342 : 3454352 .",.}	{"Diabetologia 50 : 231347 .","Veiga-da-Cunha l \\\\ ’ I , Courtois S , Nlichel A , Gosselain E , Van Schaftingen E ( 1996 ) Amino acid conservation in animal glucokinases ."}	0.796	0.95	0.986	{"WORD_SEQ_[gene in]",POS_SEQ_[NNS_IN],DEP_PATH_POS_[nn-prep_of|NNS-conj_and|NNS-dobj|CD@prep_in],DEP_PATH_[nn-prep_of|gene-conj_and|mutation-dobj|NUMBER@prep_in]}	{1.4523,-1.30742,0.725162,0.31308}
journal.pone.0014299.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0014299.pdf_7_7_37_37_31_31	CCL11/HP:0002099|Asthma	{37}	{31}	{Methodology/Principal,Findings,:,In,this,study,we,investigated,serum,samples,from,944,individuals,of,218,asthma,—,affected,families,by,a,multiplex,",",microsphere,based,system,detecting,at,high,sensitivity,eleven,asthma,associated,mediators,:,eotaxin,(,CCL11,),",",granulocyte,macrophage,stimulating,factor,(,GM-CSF,),",",interferon,gamma,(,IFNy,),",",interleukin-4,(,IL-4,),",",IL-5,",",IL-8,",",IL-10,",",IL-12,(,p40,),",",IL-13,",",IL-17,and,tumor,necrosis,factor,alpha,(,I,',NFol,),.}	{Abstract,"Background : Circulating cytokine patterns may be relevant for the diagnosis of asthma , for the discrimination of certain phenotypes , and prognostic factors for exacerbation of disease ."}	{"Single cytokine levels were largely similar between asthmatic and healthy individuals when analysing asthma as single disease entity .","Regulatory differences between parental and pediatric asthma were reflected by six of the eleven mediators analyzed ( eotaxin , IL-4 , IL-5 , IL-10 , IL-12 , TNFor ) ."}	0.722	0.96	0.964	{INV_DEP_PATH_[nn-dep|)-dobj|mediator-partmod|associate@],INV_DEP_PATH_POS_[nn-dep|NN-dobj|NNS-partmod|VBN@],INV_VERB_DEP_PATH_[associate]_[nn-dep|)-dobj|mediator@]_[@partmod],INV_VERB_DEP_PATH_POS_[associate]_[nn-dep|NN-dobj|NNS@]_[@partmod],"INV_WORD_SEQ_NER_[associate mediator : eotaxin NUMBER]",INV_POS_SEQ_[VBN_NNS_:_NN_CD],"INV_WORD_SEQ_[associate mediator : eotaxin (]"}	{0.276874,0.276874,0.276874,0.276874,0,0,0}
SCPDFS_43524.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_43524.pdf_677_677_22_22_29_30	MHS/HP:0002047|Malignant hyperthermia	{22}	{29,30}	{High,resolution,physical,mapping,of,four,microsatellite,repeat,markers,near,the,RYR1,locus,on,chromosome,19qI3,.1,and,apparent,exclusion,of,the,MHS,locus,from,this,region,in,two,malignant,hyperthermia,susceptible,families,.}	{"20 : 1170 .","Iles , D. E. , Segers , B. , Heytens , L. , Sengers , R. C. A. , and Wieringa , B. ( 19920 ) ."}	{"Genomics 14 : 749-754 .","Joslyn , G. , Carlson , M. , Thliveris , A. , Albertsen , H. , Gelbert , L. , Samowitz , W. , Groden , J. , Stevens , J. , Spirio , L. , Robertsen , M. , Sargent , L. , Krapcho , K. , Wolff , E. , Burt , R. , Hughes , J. P. , Warrington , J. , McPherson , J. , Wasmuth , J. , Le Paslier , D. , Abderrahim , H. , Cohen , D. , Leppert , M. , and White , R. ( 1991 ) ."}	0.772	0.052	0.988	{DEP_PATH_[nn-prep_of|locus@amod-prep_in|family],DEP_PATH_POS_[nn-prep_of|NN@amod-prep_in|NNS],"WORD_SEQ_NER_[locus from this region in NUMBER]",POS_SEQ_[NN_IN_DT_NN_IN_CD],"WORD_SEQ_[locus from this region in two]"}	{0.585678,-0.421699,0.352117,0.352117,0.352117}
journal.pone.0036690.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0036690.pdf_618_618_17_17_31_31	HERG/HP:0011675|Arrhythmia	{17}	{31}	{Langheinrich,U,",",Vacun,G,",",VVagner,T,(,2003,),Zebrafish,embryos,express,an,orthologue,of,HERG,and,are,sensitive,toward,a,range,of,QT,—,prolonging,drugs,inducing,severe,arrhythmia,.}	{"1 \\\\ Iilan DJ , Peterson TA , Ruskin JN , Peterson RT , lVIacRae CA ( 2003 ) Drugs that induce repolarization abnormalities cause bradycardia in zebrafish .","Circulation 107 : 135541358 ."}	{"Toxicol Appl Pharmacol 193 : 3704382 .","Presta 1 \\\\ ’ I , Dell ’ Era P , Nlitola S , Nloroni E , Ronca R , et al. ( 2005 ) Fibroblast growth factor / fibroblast growth factor receptor system in angiogenesis ."}	0.734	0.068	0.984	{DEP_PATH_POS_[prep_of-dobj|NN@dobj-xcomp|VBG-partmod|VBG-prep_of|NN-prep_toward|NN-conj_and|JJ],"WORD_SEQ_[and be sensitive toward a range of qt — prolong drug induce severe]",POS_SEQ_[CC_VBP_JJ_IN_DT_NN_IN_NN_CD_VBG_NNS_VBG_JJ],"WORD_SEQ_NER_[and be sensitive toward a range of qt NUMBER prolong drug induce severe]",DEP_PATH_[prep_of-dobj|orthologue@dobj-xcomp|induce-partmod|prolong-prep_of|qt-prep_toward|range-conj_and|sensitive]}	{0.196673,0.196673,0.196673,0.196673,0.196673}
SCPDFS_39036.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_39036.pdf_322_322_1_1_10_11	HESX1/HP:0100842|Septo-optic dysplasia	{1}	{10,11}	{Heterozygous,HESX1,mutations,associated,with,isolated,congenital,pituitary,hypoplasia,and,septo-optic,dysplasia,.}	{"4 .","Thomas , P. Q. , et al. ( 2001 ) ."}	{"Hum .","Mol ."}	0.78	0.824	0.992	{DEP_PATH_[nn-nsubj|mutation@prep_with],DEP_PATH_POS_[nn-nsubj|NNS@prep_with],VERB_DEP_PATH_[associate]_[nn-nsubj|mutation@]_[prep_with@],VERB_DEP_PATH_POS_[associate]_[nn-nsubj|NNS@]_[prep_with@],"WORD_SEQ_[mutation associate with isolate congenital pituitary hypoplasium and]",POS_SEQ_[NNS_VBN_IN_VBN_JJ_JJ_NN_CC]}	{1.22185,-0.855746,0.331035,0.244827,0.19821,0.19821}
journal.pone.0055031.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0055031.pdf_733_733_20_20_32_32	PLA2G6/HP:0001332|Dystonia	{20}	{32}	{Engel,LA,",",Jing,Z,",",O’Brien,DE,",",Sun,NI,",",Kotzbauer,PT,(,2010,),Catalytic,function,of,PLA2G6,is,impaired,by,mutations,associated,with,infantile,neuroaxonal,dystrophy,but,not,dystonia,~,parkinsonism,.}	{"Kotzbauer PT , Giasson BI , Kravitz AV , Golbe LI , Nlark lV1H , et al. ( 2004 ) Fibrillization of alpha ~ sy ' nuc1ein and tau in familial Parkinson ’s disease caused by the A53T alpha-synuclein mutation .","Exp Neurol 187 : 279 * 288 ."}	{"PLoS ONE 5 : el2897 .","Giasson BI , Duda JE , lV1urray IV , Chen Q Souza JlV1 , et al. ( 2000 ) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions ."}	0.704	0.198	0.954	{POS_SEQ_[VBZ_VBN_IN_NNS_VBN_IN_JJ_JJ_NN_CC_RB],DEP_PATH_POS_[prep_of-dep|NN-nsubjpass|NNP@nn-conj_negcc|NN-prep_with|NN-partmod|VBN-agent|NNS],DEP_PATH_[prep_of-dep|function-nsubjpass|ORGANIZATION@nn-conj_negcc|parkinsonism-prep_with|dystrophy-partmod|associate-agent|mutation],"WORD_SEQ_[be impair by mutation associate with infantile neuroaxonal dystrophy but not]"}	{0.200148,0.200148,0.200148,0.200148}
journal.pone.0017220.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0017220.pdf_484_484_6_6_4_4	MLL/HP:0001909|Leukemia	{6}	{4}	{In,23,acute,lymphoblastic,leukemias,with,MLL,translocations,",",two,signatures,correlating,with,prognosis,were,found,[,30,],.}	{"— .","Y in cellular transformation ?"}	{"Top rank genes were HspCBF , an NF .","— ."}	0.798	0.824	1	{INV_POS_SEQ_[IN],INV_WORD_SEQ_[with],INV_DEP_PATH_[nn-prep_with|translocation@],INV_DEP_PATH_POS_[nn-prep_with|NNS@],INV_VERB_DEP_PATH_POS_[be]_[nn-prep_with|NNS-prep_in|NNS@auxpass]_[prep_in@auxpass],INV_VERB_DEP_PATH_POS_[find]_[nn-prep_with|NNS-prep_in|NNS@]_[prep_in@],INV_VERB_DEP_PATH_[be]_[nn-prep_with|translocation-prep_in|leukemia@auxpass]_[prep_in@auxpass],INV_VERB_DEP_PATH_[find]_[nn-prep_with|translocation-prep_in|leukemia@]_[prep_in@]}	{-1.42772,1.22758,0.947167,0.423622,0.201155,0,0,0}
SCPDFS_20182.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_20182.pdf_201_201_27_27_31_31	ATM/HP:0001009|Telangiectasia	{27}	{31}	{Although,not,recognized,in,the,gene,ontology,",",the,ﬁve,member,cluster,is,enriched,for,genetic,diseases,:,Werner,syndrome,(,WRN,),",",ataxia,telangiectasia,(,ATM,),",",ataxia,telangiectasia,like,disorder,(,MRE11A,),",",Kabuki,syndrome,(,MLL2,),and,susceptibility,to,Alzheimer,disease,(,PAXIP1,),.}	{"Interacting proteins encoded by transcripts recovered in the screens with the UTRs from polyQ SCA mRNAs .","A. Interacting proteins from the ATXN1 UTR screen ."}	{"B. Interacting proteins from the screen with CACNA1A UTRs .","C. Clusters of interacting proteins from the ATXN3 UTR screen ."}	0.72	0.004	1	{DEP_PATH_POS_[dep-conj_and|NN@conj_and],"WORD_SEQ_NER_[NUMBER , ataxia]","POS_SEQ_[CD_,_NN]","WORD_SEQ_[) , ataxia]",VERB_DEP_PATH_POS_[enrich]_[dep-conj_and|NN-dep|NN-parataxis|NN@]_[conj_and-dep|NN-parataxis|NN@],VERB_DEP_PATH_[enrich]_[dep-conj_and|telangiectasium-dep|syndrome-parataxis|)@]_[conj_and-dep|syndrome-parataxis|)@],DEP_PATH_[dep-conj_and|telangiectasium@conj_and]}	{-0.9626,0.68488,0.580237,0.465072,0,0,0}
journal.pone.0076947.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0076947.pdf_515_515_24_24_39_40	BMPR2/HP:0002092|Pulmonary hypertension	{24}	{39,40}	{Hamid,R,",",Hedges,LK,",",Austin,E,",",Phillips,JA,3rd,",",Loyd,JE,et,al.,(,2010,),Transcripts,from,a,novel,BMPR2,termination,mutation,escape,nonsense,mediated,decay,by,downstream,translation,re-initiation,:,implications,for,treating,pulmonary,hypertension,.}	{"doi :10.1164 / rccm.200602-1650C .","PubMed : 16728714 ."}	{"Clin Genet 77 : 280-286 .","doi :10.1111 / j.1399-0004 .2009.01311 ."}	0.764	0.194	0.998	{DEP_PATH_[nn-prep_from|nonsense-dep|(-nsubj|JE@dobj-prepc_for|treat-dep|implication-prep_by|re-initiation],DEP_PATH_POS_[nn-prep_from|NN-dep|FW-nsubj|NNP@dobj-prepc_for|VBG-dep|NNS-prep_by|NN],POS_SEQ_[NN_NN_NN_NN_VBD_NN_IN_JJ_NN_NN_:_NNS_IN_VBG],VERB_DEP_PATH_POS_[mediate]_[nn-prep_from|NN-dep|FW-nsubj|NNP@]_[dobj-prepc_for|VBG-dep|NNS-prep_by|NN@],"WORD_SEQ_[termination mutation escape nonsense mediate decay by downstream translation re-initiation : implication for treat]",VERB_DEP_PATH_[mediate]_[nn-prep_from|nonsense-dep|(-nsubj|JE@]_[dobj-prepc_for|treat-dep|implication-prep_by|re-initiation@]}	{0.218815,0.218815,0.218815,0.218815,0.218815,0.218815}
SCPDFS_1271.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_1271.pdf_803_803_18_18_1_2	SOX9/HP:0012245|Sex reversal	{18}	{1,2}	{Autosomal,sex,reversal,and,campomelic,dysplasia,are,caused,by,mutations,in,and,around,the,SRY,—,related,gene,SOX9,.}	{", Pasantes , ] , , Bricarelli , F.D. , Keutel , ] .",", Hustert , E , , Wolf , U. , Tommerup , N , , Schempp , W. , Scherer , G. , 1994 ."}	{"Cell 79 , 1111-1120 .","Yao , H , H. , DiNapoli , L. , Capel , B. , 2003 ."}	0.742	0.578	0.998	{INV_VERB_DEP_PATH_POS_[cause]_[prep_in@]_[nsubjpass@],INV_VERB_DEP_PATH_[cause]_[prep_in@]_[nsubjpass@],INV_WORD_SEQ_[TOO_FAR_AWAY],INV_VERB_DEP_PATH_[be]_[prep_in@auxpass]_[nsubjpass@auxpass],INV_VERB_DEP_PATH_POS_[be]_[prep_in@auxpass]_[nsubjpass@auxpass],INV_DEP_PATH_POS_[prep_in@nsubjpass],INV_DEP_PATH_[prep_in@nsubjpass]}	{2.47075,2.47075,-2.15153,-0.603506,-0.603506,-0.233899,-0.233899}
SCPDFS_12.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_12.pdf_437_437_3_3_1_1	FANCA/HP:0001903|Anemia	{3}	{1}	{Fanconi,anemia,proteins,FANCA,",",FANCC,",",and,FANCG/XRCC9,interact,in,a,functional,nuclear,complex,.}	{"Higuera , | .",", Kuang , Y. , Naf , D. , Wasik , J. , and D‘Andrea , A.D. ( 1999 ) ."}	{"Mol .","Cell ."}	0.704	0.916	0.946	{INV_VERB_DEP_PATH_POS_[interact]_[dep-nsubj|NNS@]_[nn-nsubj|NNS@],INV_VERB_DEP_PATH_[interact]_[dep-nsubj|protein@]_[nn-nsubj|protein@],INV_WORD_SEQ_[protein],INV_DEP_PATH_POS_[dep@nn],INV_DEP_PATH_[dep@nn],INV_POS_SEQ_[NNS]}	{0.887202,0.887202,0.650967,-0.548515,-0.54802,-0.437713}
journal.pone.0019120.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0019120.pdf_436_436_1_1_7_7	CFTR/HP:0000027|Azoospermia	{1}	{7}	{Reduced,CFTR,and,CREB,expression,in,human,azoospermia,testes,.}	{"p | osone.org","Figure 4 ."}	{"( A ) Representative immunoinfluoresence staining of CFTR ( red ) and Protamine — 2 ( green ) in normal human ( n = 5 ) and azoospermia patients ( n = 6 ) testes , counterstained with Hoechst ( blue ) .","In the normal human testes , Protamine — 2 positive signals are localized in the round spermatids ( RS , yellow arow ) and elongated spermatids ( ES , white arrow ) ( Stages | ."}	0.756	0.09	0.938	{POS_SEQ_[CC_NN_NN_IN_JJ],DEP_PATH_POS_[dep@nn-prep_in|NNS],VERB_DEP_PATH_[reduce]_[dep@]_[nn-prep_in|testis@],"WORD_SEQ_[and creb expression in human]",DEP_PATH_[dep@nn-prep_in|testis],VERB_DEP_PATH_POS_[reduce]_[dep@]_[nn-prep_in|NNS@]}	{0.546897,0.3536,0,0,0,0}
journal.pone.0003581.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0003581.pdf_275_275_18_18_26_28	BHD/HP:0005584|Renal cell carcinoma	{18}	{26,27,28}	{By,developing,and,subsequently,analyzing,the,conditional,BHD,knockout,mouse,model,",",we,demonstrate,that,the,deletion,of,BHD,in,the,mouse,kidney,leads,to,cystic,renal,cell,carcinoma,(,cystic,RCC,),in,addition,to,polycystic,kidney,and,hyperplasia,.}	{"— .","N ) ."}	{"The cystic RCC was only observed in the older affected mice ( 220 days old ) .","This implies that most of the polycystic kidneys would only present regular cysts and various extents of hyperplasia if the affected mice are sacriﬁced earlier ."}	0.714	0.504	1	{VERB_DEP_PATH_POS_[lead]_[prep_of-nsubj|NN@]_[prep_to@],POS_SEQ_[IN_DT_NN_NN_VBZ_TO_JJ],DEP_PATH_[prep_of-nsubj|deletion@prep_to],VERB_DEP_PATH_[lead]_[prep_of-nsubj|deletion@]_[prep_to@],DEP_PATH_POS_[prep_of-nsubj|NN@prep_to],VERB_DEP_PATH_POS_[demonstrate]_[prep_of-nsubj|NN-ccomp|VBZ@]_[prep_to-ccomp|VBZ@],"WORD_SEQ_[in the mouse kidney lead to cystic]",VERB_DEP_PATH_[develop]_[prep_of-nsubj|deletion-ccomp|lead@prepc_by]_[prep_to-ccomp|lead@prepc_by],VERB_DEP_PATH_POS_[develop]_[prep_of-nsubj|NN-ccomp|VBZ@prepc_by]_[prep_to-ccomp|VBZ@prepc_by],VERB_DEP_PATH_[demonstrate]_[prep_of-nsubj|deletion-ccomp|lead@]_[prep_to-ccomp|lead@]}	{0.897882,-0.142516,0.10927,0.10927,-0.0304716,0,0,0,0,0}
journal.pone.0045129.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0045129.pdf_696_696_23_23_28_28	p53/HP:0002664|Neoplasm	{23}	{28}	{Reincke,1,"\\\\",’,I,",",Karl,IVI,",",Travis,VVH,",",1Vlastorakos,G,",",Allolio,B,",",et,al.,(,1994,),p53,mutations,in,human,adrenocortical,neoplasms,:,immunohistochemical,and,molecular,studies,.}	{"Cerquetti L , Bucci B , Nlarchese R , 1\\\\/Iisiti S , De Paula U , et al. ( 2008 ) 1Vlitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SVV13 adrenocortical cell lines .","Endocr Relat Cancer 15 : 6234634 ."}	{"J Clin Endocrinol Nletab 78 ( 3 ) : 7904794 .","Yaginuma Y , I/Vestphal H ( 1992 ) Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines ."}	0.798	0.864	0.996	{POS_SEQ_[NNS_IN_JJ_JJ],DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],"WORD_SEQ_[mutation in human adrenocortical]"}	{0.386778,0.374951,0.356655,0.293763}
journal.pone.0045058.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0045058.pdf_445_445_34_34_29_30	p53/HP:0003003|Colon cancer	{34}	{29,30}	{Based,on,these,ﬁndings,",",we,concluded,that,the,activation,of,AMPK,serves,as,a,central,mediator,in,the,induction,of,cytoprotective,autophagy,in,response,to,DNA,damage,in,colon,cancer,cells,containing,wild-type,p53,but,not,mutant,p53,.}	{"6 , the combined treatment of topotecan with compound C resulted in an increased level of cytotoxicity in human colon cancer cells with wild-type p53 ( HCTll6 and LSI74-T cell lines ) .","However , compound C treatment did not sensitise cells with mutant p53 ( HT29 , SW48O and SW620 cell lines ) to topotecan treatment ."}	{"The Anti — tumour Activity of Topotecan in Combination with the Autophagy Inhibitor in a HCT116 Human Colon Cancer Xenograft Model To explore the in vivo effectiveness of the autophagy inhibitor CQ to sensitise wild-type p53 human colon cancer cells to topotecan treatment , a xenograft model in nude mice was generated .","Athymic nude mice were injected subcutaneously with 4 > < 106 HCT1 16 p53 + / + or HCT1 16 p53 _ / _ cancer cells , and the resulting tumours were allowed to grow for approximately 5 d to produce an average tumour volume of 40 mm3 prior to drug treatment ."}	0.738	0.932	1	{INV_POS_SEQ_[NNS_VBG_JJ],INV_DEP_PATH_[dobj-partmod|contain@nn],INV_VERB_DEP_PATH_POS_[contain]_[dobj@]_[nn@partmod],INV_VERB_DEP_PATH_[contain]_[dobj@]_[nn@partmod],INV_DEP_PATH_POS_[dobj-partmod|VBG@nn],INV_VERB_DEP_PATH_[serve]_[dobj-partmod|contain-prep_in|cell-prep_to|damage@]_[nn-prep_in|cell-prep_to|damage@],"INV_WORD_SEQ_[cell contain wild-type]",INV_VERB_DEP_PATH_POS_[serve]_[dobj-partmod|VBG-prep_in|NNS-prep_to|NN@]_[nn-prep_in|NNS-prep_to|NN@]}	{0.86232,0.011596,0.011596,0.011596,-0.0024175,0,0,0}
journal.pone.0073522.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0073522.pdf_4_4_21_21_10_11	SPINK1/HP:0006280|Chronic pancreatitis	{21}	{10,11}	{A,Conservative,Assessment,of,the,Major,Genetic,Causes,of,Idiopathic,Chronic,Pancreatitis,:,Data,from,a,Comprehensive,Analysis,of,PRSS1,",",SPINK1,",",CTRC,and,CFTR,Genes,in,253,Young,French,Patients}	{"- PLOS r ϘY","OPEN 8 ACCESS Freely available online"}	{"Emmanuelle Masson ” , Jian-Min Chen \\" 3 * , Marie-Pierre Audrézet ” , David N. Cooper ‘ , Claude Férec ‘ ~ 2 ' 3 ' 5 *","1 lnstitut National de la Santé et de la Recherche Médicale , U1078 , Brest , France , 2 Laboratoire de Génétique Moléculaire et d’Histocompatibi | ité , Centre Hospitalier Régional Universitaire Brest , Hopital Morvan , Brest , France , 3 Etablissement Francais du sang — Bretagne , Brest , France , 4 Institute of Medical Genetics , School of Medicine , Cardiff University , Cardiff , United Kingdom , 5 Faculté de Médecine et des Sciences de la Santé , Université de Bretagne Occidentale , Brest , France"}	0.726	0.822	0.998	{"INV_POS_SEQ_[:_NNS_IN_DT_JJ_NN_IN_NN_,]","INV_WORD_SEQ_[: datum from a comprehensive analysis of prss1 ,]","INV_WORD_SEQ_NER_[: datum from a MISC MISC MISC MISC ,]",INV_DEP_PATH_POS_[nn-prep_of|NNS-prep_from|NN-dep|NNS@prep_of-prep_of|NNS],INV_DEP_PATH_[nn-prep_of|gene-prep_from|MISC-dep|datum@prep_of-prep_of|cause]}	{0.276666,0.276666,0.276666,0,0}
journal.pone.0002722.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0002722.pdf_86_86_4_4_12_12	MYC/HP:0002665|Lymphoma	{4}	{12}	{Our,global,mapping,of,MYC,binding,sites,in,a,human,B,cell,lymphoma,model,identiﬁed,over,2000,binding,sites,with,668,direct,Myc,target,genes,gleaned,from,accompanying,microarray,gene,expression,analysis,[,33,],.}	{"Although Myc ’s regulation of glucose metabolism has been well delineated , the connection between Myc and purine or pyrimidine metabolism is not well understood .","It stands to reason , however , that a master regulator such as Myc must somehow couple cell cycle traversal through S-phase with regulation of nucleotide metabolism and energy generation ."}	{"Among the direct Myc target genes is a statistically over-represented small set involved in nucleotide metabolism .","This observation led us to determine comprehensively whether genes involved in both purine and pyrimidine synthesis pathways are directly regulated by Myc ."}	0.792	0.712	1	{DEP_PATH_[nn@nn-prep_in|model],DEP_PATH_POS_[nn@nn-prep_in|NN],"WORD_SEQ_[binding site in a human b cell]",VERB_DEP_PATH_[identiﬁed]_[nn-prep_of|site-nsubj|mapping@]_[nn-prep_in|model-prep_of|site-nsubj|mapping@],VERB_DEP_PATH_POS_[identiﬁed]_[nn-prep_of|NNS-nsubj|NN@]_[nn-prep_in|NN-prep_of|NNS-nsubj|NN@],POS_SEQ_[NN_NNS_IN_DT_JJ_NN_NN]}	{1.1719,0.0140987,0,0,0,0}
SCPDFS_3553.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_3553.pdf_48_48_5_5_8_8	RX/HP:0000528|Anophthalmia	{5}	{8}	{In,humans,",",mutations,in,RX,result,in,anophthalmia,or,microphthalmia,(,Voronina,et,al.,",",2004,),",",a,phenotype,predicted,by,the,mouse,knockout,of,Rx,(,Mathers,et,al.,",",1997,),.}	{"The retinal homeobox genes ( Rx/Rax ) also have important functions related to eye development .","The Rx gene product contains conserved domains including an N — terminal octapeptide domain , a homeodomain , an Rx domain , and a C — terminal orthopedia — aristaless — rx domain ( Mathers et al. , 1997 ; Pan et al. , 2006 ) ."}	{"Loss of rx3 expression in zebraﬁsh and medaka also results in an eyeless phenotype ( Loosli et al. , 2003 ; Rojas .","— ."}	0.748	0.332	0.998	{DEP_PATH_[prep_in-nsubj|mutation@prep_in],POS_SEQ_[VBP_IN],VERB_DEP_PATH_[result]_[prep_in-nsubj|mutation@]_[prep_in@],DEP_PATH_POS_[prep_in-nsubj|NNS@prep_in],VERB_DEP_PATH_POS_[result]_[prep_in-nsubj|NNS@]_[prep_in@],"WORD_SEQ_[result in]"}	{0.575043,-0.411764,0.380037,0.276557,0.203356,0.0259271}
journal.pone.0049570.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0049570.pdf_412_412_10_10_12_12	NF1/HP:0009733|Glioma	{10}	{12}	{We,conﬁrmed,that,CREB,can,positively,regulate,the,expression,of,NF1,in,glioma,cells,",",which,might,explain,the,migration-inhibitory,role,of,CREB,.}	{"Conversely , CREB , which has been previously identiﬁed as a proliferation enhancer of glioma cells [ 24 ] , also functions as a migration inhibitor in glioma cells .","CREB signaling was reported to positively regulate the migration of breast cancer and mesothelioma cells [ 23 ] , and there have been no reports suggesting a similar migration-inhibitory function of CREB in human malignancies ."}	{"In addition to miR — 9 and CREB , other genes have been shown to play dual roles in glioma cells .","For example , under normal glucose conditions , elevated levels of miR-451 promote cell proliferation and decrease cell migration , while in a glucose-scarce environment , a decrease in miR-451 slows the proliferation and enhances the migration of glioma cells [ 32 ] ."}	0.756	0.85	1	{POS_SEQ_[IN],WORD_SEQ_[in],DEP_PATH_POS_[prep_of-dobj|NN@nn-prep_in|NNS],DEP_PATH_[prep_of-dobj|expression@nn-prep_in|cell],VERB_DEP_PATH_[regulate]_[prep_of-dobj|expression@]_[nn-prep_in|cell@],VERB_DEP_PATH_POS_[regulate]_[prep_of-dobj|NN@]_[nn-prep_in|NNS@],VERB_DEP_PATH_[conﬁrmed]_[prep_of-dobj|expression-ccomp|regulate@]_[nn-prep_in|cell-ccomp|regulate@],VERB_DEP_PATH_POS_[explain]_[prep_of-dobj|NN@rcmod-prep_in|NNS]_[nn@rcmod],VERB_DEP_PATH_POS_[conﬁrmed]_[prep_of-dobj|NN-ccomp|VB@]_[nn-prep_in|NNS-ccomp|VB@],VERB_DEP_PATH_[explain]_[prep_of-dobj|expression@rcmod-prep_in|cell]_[nn@rcmod]}	{-1.75808,1.42594,0.920263,0.51322,0,0,0,0,0,0}
journal.pone.0080923.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0080923.pdf_28_28_4_4_17_18	HD/HP:0004305|Involuntary movements	{4}	{17,18}	{Huntington,’s,disease,(,HD,),is,a,dominantly,inherited,neurodegenerative,disorder,characterized,by,abnormal,voluntary,and,involuntary,movements,",",cognitive,impairment,and,psychiatric,disturbances,.}	{"p | osone.org 1 November 2013 | Volume 8 | Issue 11 | e80923",Introduction}	{"Onset typically occurs in mid-life , relentlessly leading to death after ~ 10-15 years [ 1 ] .","While the brain is the primary site of pathology , with neurons in the striatum and cortex being particularly vulnerable , multiple nonneuronal abnormalities including weight loss and cardiac failure occur in the disease [ 2 ] ."}	0.76	0.054	1	{VERB_DEP_PATH_[inherit]_[nn-nsubj|)@amod]_[agent-partmod|characterize@amod],VERB_DEP_PATH_POS_[inherit]_[nn-nsubj|NN@amod]_[agent-partmod|VBN@amod],VERB_DEP_PATH_[be]_[nn-nsubj|)@cop]_[agent-partmod|characterize@cop],DEP_PATH_[nn-nsubj|)@agent-partmod|characterize],VERB_DEP_PATH_[characterize]_[nn-nsubj|)@partmod]_[agent@],VERB_DEP_PATH_POS_[be]_[nn-nsubj|NN@cop]_[agent-partmod|VBN@cop],DEP_PATH_POS_[nn-nsubj|NN@agent-partmod|VBN],VERB_DEP_PATH_POS_[characterize]_[nn-nsubj|NN@partmod]_[agent@],POS_SEQ_[NN_VBZ_DT_RB_VBN_JJ_NN_VBN_IN_JJ_JJ_CC],"WORD_SEQ_[) be a dominantly inherit neurodegenerative disorder characterize by abnormal voluntary and]"}	{0.357443,0.357443,0.182079,0.182079,0.182079,-0.107914,-0.107914,0.083423,0,0}
SCPDFS_2931.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_2931.pdf_59_59_2_2_9_10	FMR1/HP:0000478|Abnormality of the eye	{2}	{9,10}	{Downregulation,of,FMR1,as,well,as,FXR1,led,to,abnormal,eye,and}	{"Many studies revealed an involvement of miRNAs during neural development ( Hornstein et al. , 2005 ; Choi et al. , 2008 ; Zhang et al. , 2008 ; Papagiannakopoulos and Kosik , 2009 ; Peter , 2009 ; Qiu et al. , 2009 ; Walker and Harland , 2009 ) .","Here we analyzed for the ﬁrst time the function of FMR1 and FXR1 during early anterior neural development in Xenopus laevis by use of a morpholino oligonucleotide ( MO ) based knock down approach ."}	{"S. Gessert et al. / Developmental Biology 341 ( 2010 ) 222-235 223","cranial cartilage development ."}	0.708	0.948	0.994	{VERB_DEP_PATH_POS_[lead]_[prep_of-nsubj|NN@]_[prep_to@],DEP_PATH_POS_[prep_of-nsubj|NN@prep_to],VERB_DEP_PATH_[lead]_[prep_of-nsubj|downregulation@]_[prep_to@],POS_SEQ_[RB_RB_IN_NN_VBD_TO],"WORD_SEQ_[as well as fxr1 lead to]",DEP_PATH_[prep_of-nsubj|downregulation@prep_to]}	{0.897882,-0.0304716,0,0,0,0}
journal.pone.0075808.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0075808.pdf_576_576_25_25_31_31	COL4A1/HP:0001297|Stroke	{25}	{31}	{Gould,DB,",",Phalan,FC,",",van,1,"\\\\",’,Iil,SE,",",SundbergJP,",",Vahedi,K,",",et,al.,(,2006,),Role,of,COL4A1,in,small-vessel,disease,and,hemorrhagic,stroke,.}	{"Alamowitch S , Plaisier E , Favrole P , Prost C , Chen Z , et al. ( 2009 ) Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome .","Neurology 73 : 187341882 ."}	{"N Eng1J 1 \\\\ ’ Ied 354 : 1489 * 1496 .","Sibon I , Coupry I , Nlenegon P , Bouchet JP , Gorry P , et al. ( 2007 ) COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke ."}	0.758	0.574	1	{DEP_PATH_POS_[prep_of-dobj|NN@prep_in],"WORD_SEQ_[in small-vessel disease and hemorrhagic]",DEP_PATH_[prep_of-dobj|role@prep_in],POS_SEQ_[IN_JJ_NN_CC_JJ]}	{0.536635,0.517784,0.210715,-0.1481}
journal.pone.0026021.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0026021.pdf_77_77_0_0_7_7	AGT/HP:0003159|Hyperoxaluria	{0}	{7}	{AGT,and,GR,are,mutated,within,primary,hyperoxaluria,(,type,1,and,2,",",respectively,),patients,resulting,in,the,buildup,of,glyoxylate,and,its,conversion,by,lactate,dehydrogenase,(,LDH,),to,oxalate,",",a,key,component,of,kidney,stones,.}	{"The terminal HOGA reaction cleaves 4 — hydroxy — 2 — oxog | utarate ( HOG ) into pyruvate and glyoxylate .","Glyoxylate is metabolized either to glycolate by glyoxylate reductase ( GR ) in the mitochondria and cytoplasm or to glycine by peroxisomal a | anine — g | yoxylate aminotransferase ( AGT ) ."}	{"doi :10.1371 / journa | .","pone ."}	0.748	0.444	0.998	{VERB_DEP_PATH_POS_[mutate]_[nsubjpass@]_[nn-prep_within|NN@],DEP_PATH_[nsubjpass@nn-prep_within|type],VERB_DEP_PATH_[be]_[nsubjpass@auxpass]_[nn-prep_within|type@auxpass],VERB_DEP_PATH_POS_[be]_[nsubjpass@auxpass]_[nn-prep_within|NN@auxpass],DEP_PATH_POS_[nsubjpass@nn-prep_within|NN],VERB_DEP_PATH_[mutate]_[nsubjpass@]_[nn-prep_within|type@],POS_SEQ_[CC_NN_VBP_VBN_IN_JJ],"WORD_SEQ_[and gr be mutate within primary]"}	{0.18154,0.18154,0.18154,0.18154,0.18154,0.18154,0,0}
journal.pone.0014311.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0014311.pdf_33_33_4_4_14_15	HD/HP:0004305|Involuntary movements	{4}	{14,15}	{Huntington,’s,disease,(,HD,),is,an,autosomal,dominant,neurodegenerative,disorder,characterized,by,involuntary,movements,",",psychiatric,disturbances,and,cognitive,decline,.}	{"TROTT | ER@igbmc.fr U Current address : INSERM UMR 991 , University of Rennes 1 , Rennes , France",Introduction}	{"The pathology , which is characterized by a severe atrophy of the striatum , is due to an abnormal CAG repeat expansion in exon 1 of the HD gene that is translated into a polyglutamine ( po1y @ expansion at the Nterminus of huntingtin ( Htt ) [ 1 ] .","HD belongs to a group of 10 inherited neurodegenerative disorders , including 7 dominant spinocerebellar ataxias ( SCAs ) , that are caused by polyQ expansion in speciﬁc disease proteins [ 2 ] ."}	0.756	0.026	1	{POS_SEQ_[NN_VBZ_DT_JJ_JJ_JJ_NN_VBN_IN],"WORD_SEQ_[) be a autosomal dominant neurodegenerative disorder characterize by]",DEP_PATH_[nn-nsubj|)@agent-partmod|characterize],VERB_DEP_PATH_[be]_[nn-nsubj|)@cop]_[agent-partmod|characterize@cop],VERB_DEP_PATH_[characterize]_[nn-nsubj|)@partmod]_[agent@],VERB_DEP_PATH_POS_[be]_[nn-nsubj|NN@cop]_[agent-partmod|VBN@cop],DEP_PATH_POS_[nn-nsubj|NN@agent-partmod|VBN],VERB_DEP_PATH_POS_[characterize]_[nn-nsubj|NN@partmod]_[agent@]}	{0.461393,0.347555,0.182079,0.182079,0.182079,-0.107914,-0.107914,0.083423}
journal.pmed.0030156.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pmed.0030156.pdf_290_290_22_22_42_42	SDH/HP:0002666|Pheochromocytoma	{22}	{42}	{Since,then,",",the,role,of,mitochondria,in,cancer,is,further,highlighted,through,identiﬁcation,of,over,100,mutations,in,the,SDHB,",",SDH,C,",",and,SDHD,subunit,genes,in,hundreds,of,index,cases,and,families,with,hereditary,and,sporadic,paragangliomas,and,pheochromocytomas,[,3,],.}	{"March 2006 | Vo | ume3 | | ssue3 | e167 | e156","The causal link between mitochondrial abnormalities and tumorigenesis was provided by the positional cloning of the hereditary paraganglioma gene at chromosome band llq23 as the SDHD subunit gene of mitochondrial complex II ( succinate dehydrogenase ) in the year 2000 [ 2 ] ."}	{"Furthermore , fumarase gene mutations in a distinct hereditary tumor syndrome characterized by multiple skin and uterine leiomyomatosis and renal cell cancer — hereditary leiomyomatosis renal cancer ( HLRCC ) .","— ."}	0.79	0.924	1	{WORD_SEQ_[TOO_FAR_AWAY],DEP_PATH_[nn-conj_and|c-prep_in|sdhb-prep_of|mutation-prep_through|identiﬁcation@prep_with],DEP_PATH_POS_[nn-conj_and|NN-prep_in|NN-prep_of|NNS-prep_through|NN@prep_with]}	{-2.70289,2.04397,2.04397}
journal.pgen.0030009.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.0030009.pdf_774_774_20_20_27_27	MC1R/HP:0002861|Melanoma	{20}	{27}	{Landi,MT,",",Bauer,],",",Pfeiffer,RM,",",Elder,DE,",",Hulley,B,",",et,al.,(,2006,),MC1R,germline,variants,confer,risk,for,BRAF-mutant,melanoma,.}	{"van der Velden PA , Sandkuijl LA , Bergman W , Pavel S , van Mourik L , et al. ( 2001 ) Melanocortin-1 receptor variant R151C modiﬁes melanoma risk in Dutch families with melanoma .","Am ] Hum Genet 69 : 774 — 779 ."}	{"Science 313 : 521-522 .","Yamaguchi Y , Takahashi K , Zmudzka BZ , Kornhauser A , Miller SA , et al. ( 2006 ) Human skin responses to UV radiation : Pigment in the upper epidermis protects against DNA damage in the lower epidermis and facilitates apoptosis ."}	0.718	0.766	0.998	{VERB_DEP_PATH_POS_[confer]_[nn-dep|NNS-nsubj|NNP@]_[prep_for-dobj|NN@],"WORD_SEQ_[germline variant confer risk for braf-mutant]",DEP_PATH_POS_[nn-dep|NNS-nsubj|NNP@prep_for-dobj|NN],POS_SEQ_[NN_NNS_VBP_NN_IN_JJ],VERB_DEP_PATH_[confer]_[nn-dep|variant-nsubj|LOCATION@]_[prep_for-dobj|risk@],DEP_PATH_[nn-dep|variant-nsubj|LOCATION@prep_for-dobj|risk]}	{0.240048,0.240048,0.240048,0.240048,0,0}
journal.pone.0006097.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0006097.pdf_614_614_18_18_16_16	DAZ/HP:0000027|Azoospermia	{18}	{16}	{moto,1,"\\\\",’,I,(,2000,),Caenorhal,),ditis,elegans,homologue,of,the,human,azoospermia,factor,DAZ,is,required,for,oogenesis,but,not,for,spermatogenesis,.}	{.,"Karashima T , Sugimoto A , Yama ."}	{"Development 127 : 106941079 .",.}	0.744	0.39	0.764	{INV_POS_SEQ_[NN],INV_WORD_SEQ_[factor],INV_VERB_DEP_PATH_[be]_[prep_of-nsubjpass|homologue@auxpass]_[nn-prep_of|DAZ-nsubjpass|homologue@auxpass],INV_VERB_DEP_PATH_[require]_[prep_of-nsubjpass|homologue@]_[nn-prep_of|DAZ-nsubjpass|homologue@],INV_VERB_DEP_PATH_POS_[require]_[prep_of-nsubjpass|NN@]_[nn-prep_of|NNP-nsubjpass|NN@],INV_VERB_DEP_PATH_POS_[be]_[prep_of-nsubjpass|NN@auxpass]_[nn-prep_of|NNP-nsubjpass|NN@auxpass],INV_DEP_PATH_[@nn],INV_DEP_PATH_POS_[@nn]}	{-2.77211,0.970196,0.867685,0.867685,0.867685,0.813801,-0.261945,-0.245954}
SCPDFS_42604.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_42604.pdf_324_324_3_3_10_10	c-myb/HP:0001909|Leukemia	{3}	{10}	{Relationship,between,the,c-myb,locus,and,the,6q-chromosomal,aberration,in,leukemias,and,lymphomas,.}	{"Nature 351 : 494-497 .","Barletta , C. , Pelicci , P. G. , Kenyon , L. C. , Smith , S. D. , and DallaFavera , R. ( 1987 ) ."}	{"Science 235 : 1064-1067 .","Blake , M. C. , and Azizkhan , J. C. ( 1989 ) ."}	0.774	0.138	1	{DEP_PATH_POS_[nn-prep_between|NN@prep_in],DEP_PATH_[nn-prep_between|locus@prep_in],"WORD_SEQ_[locus and the 6q-chromosomal aberration in]",POS_SEQ_[NN_CC_DT_JJ_NN_IN]}	{0.490477,0.362932,0.300067,0.293268}
SCPDFS_40381.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_40381.pdf_242_242_9_9_4_4	FAA/HP:0001903|Anemia	{9}	{4}	{Mutations,of,the,Fanconi,anemia,group,A,gene,(,FAA,),in,Italian,patients,.}	{"23 : 256-260 .","Savino , M. , Ianzano , L. , Strippoli , P. , Ramenghi , U. , Arslanian , A. , Bagnara , G. P. , Joenje , H. , Zelante , L. , and Savoia , A. ( 1997 ) ."}	{"Am .","J. Hum ."}	0.71	0.11	0.998	{INV_DEP_PATH_POS_[dep@nn-prep_of|NN],"INV_WORD_SEQ_NER_[group a gene NUMBER]","INV_WORD_SEQ_[group a gene (]",INV_POS_SEQ_[NN_NN_NN_CD],INV_DEP_PATH_[dep@nn-prep_of|gene]}	{-0.413638,0.413476,0.413476,0.280364,0.195497}
journal.pone.0071215.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0071215.pdf_414_414_18_18_16_16	DAZ/HP:0000027|Azoospermia	{18}	{16}	{moto,l,"\\\\",’,I,(,2000,),Caenorhal,),ditis,elegans,homologue,of,the,human,azoospermia,factor,DAZ,is,required,for,oogenesis,but,not,for,spermatogenesis,.}	{"14 .","Karashima T , Sugimoto A , Yama ."}	{"Development 127 : 106941079 .","15 ."}	0.738	0.416	0.77	{INV_POS_SEQ_[NN],INV_WORD_SEQ_[factor],INV_VERB_DEP_PATH_POS_[require]_[prep_of-nsubjpass|NN@]_[nn-prep_of|NNP-nsubjpass|NN@],INV_VERB_DEP_PATH_[require]_[prep_of-nsubjpass|homologue@]_[nn-prep_of|DAZ-nsubjpass|homologue@],INV_VERB_DEP_PATH_[be]_[prep_of-nsubjpass|homologue@auxpass]_[nn-prep_of|DAZ-nsubjpass|homologue@auxpass],INV_VERB_DEP_PATH_POS_[be]_[prep_of-nsubjpass|NN@auxpass]_[nn-prep_of|NNP-nsubjpass|NN@auxpass],INV_DEP_PATH_[@nn],INV_DEP_PATH_POS_[@nn]}	{-2.77211,0.970196,0.867685,0.867685,0.867685,0.813801,-0.261945,-0.245954}
journal.pgen.1002319.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1002319.pdf_65_65_9_9_13_14	MTMR2/HP:0004336|Myelin outfoldings	{9}	{13,14}	{We,previously,demonstrated,that,loss,of,the,phospholipid,phosphatase,MTMR2,causes,CMT4B1,with,myelin,outfoldings,in,human,and,mouse,and,that,loss,of,the,phospholipid,phosphatase,FIG4,causes,CMT4J,and,neurodegeneration,in,the,mouse,.}	{"— .","Tooth type 4J ( CMT4J ) are severe autosomal recessive demyelinating neuropathies with childhood onset ."}	{"MTMR2 has a predicted role in membrane trafficking , which is crucial for myelin membrane biogenesis and homeostasis .","However , the biochemical activity of MTMR2 in vivo and the role of MTMR2 in myelination still remain to be assessed ."}	0.712	0.996	0.99	{VERB_DEP_PATH_[cause]_[prep_of-nsubj|loss@]_[prep_with@],DEP_PATH_[prep_of-nsubj|loss@prep_with],DEP_PATH_POS_[prep_of-nsubj|NN@prep_with],POS_SEQ_[VBZ_NN_IN],VERB_DEP_PATH_POS_[cause]_[prep_of-nsubj|NN@]_[prep_with@],VERB_DEP_PATH_POS_[demonstrate]_[prep_of-nsubj|NN-ccomp|VBZ@]_[prep_with-ccomp|VBZ@],VERB_DEP_PATH_POS_[cause]_[prep_of-nsubj|NN-ccomp|VBZ@ccomp]_[prep_with-ccomp|VBZ@ccomp],"WORD_SEQ_[cause cmt4b1 with]",VERB_DEP_PATH_[cause]_[prep_of-nsubj|loss-ccomp|cause@ccomp]_[prep_with-ccomp|cause@ccomp],VERB_DEP_PATH_[demonstrate]_[prep_of-nsubj|loss-ccomp|cause@]_[prep_with-ccomp|cause@]}	{0.564157,0.564157,-0.233155,-0.182801,0.100135,0,0,0,0,0}
SCPDFS_18414.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_18414.pdf_347_347_8_8_6_6	DAZ/HP:0000027|Azoospermia	{8}	{6}	{Caenorhabditis,elegans,homologue,of,the,human,azoospermia,factor,DAZ,is,required,for,oogenesis,but,not,for,spermatogenesis,.}	{"Developmental Biology 234 , 402-415 .","l ( arashima , T. , Sugimoto , A. , Yamamoto , M. , 2000 ."}	{"Development 127 , 1069-1079 .","Kobayashi , T. , Kajiura — l ( obayashi , H. , Nagahama , Y. , 2000 ."}	0.74	0.446	0.74	{INV_POS_SEQ_[NN],INV_WORD_SEQ_[factor],INV_VERB_DEP_PATH_[be]_[prep_of-nsubjpass|homologue@auxpass]_[nn-prep_of|DAZ-nsubjpass|homologue@auxpass],INV_VERB_DEP_PATH_[require]_[prep_of-nsubjpass|homologue@]_[nn-prep_of|DAZ-nsubjpass|homologue@],INV_VERB_DEP_PATH_POS_[require]_[prep_of-nsubjpass|NN@]_[nn-prep_of|NNP-nsubjpass|NN@],INV_VERB_DEP_PATH_POS_[be]_[prep_of-nsubjpass|NN@auxpass]_[nn-prep_of|NNP-nsubjpass|NN@auxpass],INV_DEP_PATH_[@nn],INV_DEP_PATH_POS_[@nn]}	{-2.77211,0.970196,0.867685,0.867685,0.867685,0.813801,-0.261945,-0.245954}
journal.pone.0028537.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0028537.pdf_655_655_29_29_34_34	DYT16/HP:0001332|Dystonia	{29}	{34}	{Seil,),ler,P,",",Djarmati,A,",",Langpap,B,",",Hagenah,J,",",Schmidt,A,",",et,al.,(,2008,),A,heterozygous,frameshift,mutation,in,PRKRA,(,DYT16,),associated,with,generalised,dystonia,in,a,German,patient,.}	{"Camargos S , Scholz S , Simon-Sanchez J , Paisan-Ruiz C , Lewis P , et al. ( 2008 ) DYT16 , a novel young-onset dystonia — parl < insonism disorder : identification ofa segregating mutation in the stress-response protein PRKRA .","Lancet Neurol 7 : 2074215 ."}	{"Lancet Neurol 7 : 3804381 .","Hrabe de Angelis 1 \\\\ ’ IH , Flaswinkel H , Fuchs H , Rathkolb B , Soewarto D , et al. ( 2000 ) Genome ~ wide , large-scale production of mutant mice by ENU mutagenesis ."}	0.76	0.036	1	{DEP_PATH_POS_[nn@prep_with-partmod|VBN],DEP_PATH_[nn@prep_with-partmod|associate],VERB_DEP_PATH_[associate]_[nn@partmod]_[prep_with@],VERB_DEP_PATH_POS_[associate]_[nn@partmod]_[prep_with@],POS_SEQ_[NN_VBN_IN_JJ],"WORD_SEQ_[) associate with generalised]"}	{-0.86172,0.675595,0.675595,0.675595,0.0126259,0}
journal.pone.0008888.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0008888.pdf_410_410_25_25_32_32	TET2/HP:0002664|Neoplasm	{25}	{32}	{Jankowska,AKI,",",Szpurka,H,",",Tiu,RV,",",KIakishima,H,",",Afable,KI,",",et,al.,(,2009,),Loss,of,heterozygosity,4q24,and,TET2,mutations,associated,with,mye1odysplastic,/,myeloproliferative,neoplasms,.}	{"N EnglJ KIed 360 : 228942301 .",.}	{"Blood 113 : 640346410 .",.}	0.742	0.69	1	{DEP_PATH_POS_[nn-conj_and|NNS@dep-prep_with|JJ-partmod|VBN],POS_SEQ_[NNS_VBN_IN_JJ_:_JJ],VERB_DEP_PATH_POS_[associate]_[nn-conj_and|NNS@partmod]_[dep-prep_with|JJ@],VERB_DEP_PATH_[associate]_[nn-conj_and|mutation@partmod]_[dep-prep_with|mye1odysplastic@],DEP_PATH_[nn-conj_and|mutation@dep-prep_with|mye1odysplastic-partmod|associate],"WORD_SEQ_[mutation associate with mye1odysplastic / myeloproliferative]"}	{0.309313,0.309313,0.309313,0,0,0}
journal.pgen.1002754.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1002754.pdf_979_979_24_24_34_35	SOX9/HP:0012245|Sex reversal	{24}	{34,35}	{Kwok,C,",",Wleller,PA,",",Guioli,S,",",FosterJVV,",",lVIansour,S,",",et,al.,(,1995,),l,"\\\\",’,Iutations,in,SOX9,",",the,gene,responsible,for,Campomelic,dysplasia,and,autosomal,sex,reversal,.}	{"Chappell L , Gorman S , Campbell F , Ellard S , Rice G , et al. ( 2008 ) A further example of a distinctive autosomal recessive syndrome comprising neonatal diabetes mellitus , intestinal atresias and gall bladder agenesis .","AmJ l \\\\ ’ Ied Genet A 146A : 171341717 ."}	{"AmJ Hum Genet 57 : 102841036 .","VVesterf1eld l \\\\ ’ I The Zebrafish Book : A Guide for the Laboratory Use of Zebrafish ( Danio rerio ) ."}	0.726	0.008	0.988	{"WORD_SEQ_[, the gene responsible for campomelic dysplasium and autosomal]","POS_SEQ_[,_DT_NN_JJ_IN_JJ_NN_CC_JJ]",DEP_PATH_POS_[prep_in-dobj|NN@conj_and-prep_for|NN],DEP_PATH_[prep_in-dobj|l@conj_and-prep_for|dysplasium]}	{0.526702,0.526702,0,0}
journal.ppat.1002220.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.ppat.1002220.pdf_635_635_29_29_33_33	beta-catenin/HP:0100242|Sarcoma	{29}	{33}	{Fujimuro,IVI,",","\\\\",/,Vu,FY,",",ApRhys,C,",",Kajumbula,H,",",Young,DB,",",et,al.,(,2003,),A,novel,viral,mechanism,for,dysregulation,of,beta-catenin,in,Kaposi,’s,sarcoma,»,associated,herpesvirus,latency,.}	{"FriborgJ , Jr. , Kong VV , Hottiger RIO , Nabel GJ ( 1999 ) p53 inhibition by the LANA protein of KSHV protects against cell death .","Nature 402 : 8894894 ."}	{"Nat l \\\\ ’ Ied 9 : 3004306 .","An FQ , Compitello N , Horwitz E , Sramkoski l \\\\ ’ I , Knudsen ES , et al. ( 2005 ) The latency-associated nuclear antigen of Kaposi ’s sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest ."}	0.786	0.126	1	{POS_SEQ_[IN_NN_POS],DEP_PATH_[prep_of-prep_for|dysregulation-dobj|mechanism@nn-prep_in|»],DEP_PATH_POS_[prep_of-prep_for|NN-dobj|NN@nn-prep_in|NN],"WORD_SEQ_[in kaposus ’s]"}	{0.733517,0.232207,0.232207,0.0845932}
journal.pone.0089410.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0089410.pdf_249_249_42_42_28_28	SCA3/HP:0001251|Ataxia	{42}	{28}	{Burk,K,",",Abele,1,"\\\\",’,I,",",Fetter,IVI,",",Dichgans,J,",",Skalej,IVI,",",et,al.,(,1996,),Autosomal,dominant,cerel,),ellar,ataxia,type,I,clinical,features,and,IVIRI,in,families,with,SCA1,",",SCA2,and,SCA3,.}	{"Neuroreport 14 : 1799 — 1802 .","5 ."}	{"Brain 119 ( Pt 5 ) : 1497 — 1505 .","6 ."}	0.758	0.25	1	{INV_DEP_PATH_[prep_with@nn-dep|type-dobj|autosomal],INV_DEP_PATH_POS_[prep_with@nn-dep|NN-dobj|NN],"INV_POS_SEQ_[NN_CD_JJ_NNS_CC_NNP_IN_NNS_IN_NN_,_NN_CC]","INV_WORD_SEQ_NER_[type NUMBER clinical feature and IVIRI in family with sca1 , sca2 and]","INV_WORD_SEQ_[type i clinical feature and IVIRI in family with sca1 , sca2 and]"}	{0.504297,0.504297,0.166919,0,0}
journal.pone.0008689.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0008689.pdf_393_393_25_25_32_34	PITX3/HP:0001115|Posterior polar cataract	{25}	{32,33,34}	{Bidinost,C,",",1VIatsumoto,IVI,",",Chung,D,",",Salem,N,",",Zhang,K,",",et,al.,(,2006,),Heterozygous,and,homozygous,mutations,in,PITX3,in,a,large,Lebanese,family,with,posterior,polar,cataracts,and,neurodevelopmental,abnormalities,.}	{"AmJ Hum Genet 79 : 3584364 .","10 ."}	{"Invest Ophthalmol Vis Sci 47 : 127441280 .","11 ."}	0.75	0.816	1	{"WORD_SEQ_NER_[in a large MISC family with]",POS_SEQ_[IN_DT_JJ_JJ_NN_IN],DEP_PATH_[prep_in-dobj|mutation@prep_with-prep_in|family],"WORD_SEQ_[in a large lebanese family with]",DEP_PATH_POS_[prep_in-dobj|NNS@prep_with-prep_in|NN]}	{0.455823,0.230111,0.163732,0.16306,0.16306}
journal.pone.0081624.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0081624.pdf_249_249_3_3_6_6	BRAF/HP:0002861|Melanoma	{3}	{6}	{But,also,in,BRAF,V600,wild-type,melanoma,immunotherapy,might,be,preferred,compared,to,(,poly,),chemotherapy,as,a,ﬁrst,line,treatment,in,patients,with,both,markers,within,the,normal,range,.}	{"In these patients , it might be beneﬁcial to postpone treatment with vemurafenib or MEK-inhibitors and initially start with immunotherapy .","Immunotherapy is characterized by longer treatment durations to achieve clinical responses as compared to inhibitor treatments ."}	{"In conclusion , the SIOOB serum level predicts overall survival in unresectable melanoma patients receiving systemic treatment .","Its relative impact is similar to LDH serum levels and the presence of brain metastases , both of which represented additional independent prognostic factors ."}	0.762	0.444	1	{POS_SEQ_[NN_JJ],DEP_PATH_POS_[nn-prep_in|NN@nn-nsubjpass|NN],VERB_DEP_PATH_POS_[be]_[nn-prep_in|NN@auxpass]_[nn-nsubjpass|NN@auxpass],VERB_DEP_PATH_POS_[prefer]_[nn-prep_in|NN@]_[nn-nsubjpass|NN@],VERB_DEP_PATH_[be]_[nn-prep_in|v600@auxpass]_[nn-nsubjpass|immunotherapy@auxpass],VERB_DEP_PATH_[prefer]_[nn-prep_in|v600@]_[nn-nsubjpass|immunotherapy@],VERB_DEP_PATH_POS_[compare]_[nn-prep_in|NN@prep]_[nn-nsubjpass|NN@prep],DEP_PATH_[nn-prep_in|v600@nn-nsubjpass|immunotherapy],"WORD_SEQ_[v600 wild-type]",VERB_DEP_PATH_[compare]_[nn-prep_in|v600@prep]_[nn-nsubjpass|immunotherapy@prep]}	{1.2672,-0.143773,-0.143773,0,0,0,0,0,0,0}
journal.pone.0080860.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0080860.pdf_284_284_30_30_18_18	PAX9/HP:0000677|Oligodontia	{30}	{18}	{Bergendal,B,",",Klar,J,",",Stecksén-Blicks,C,",",Norderyd,J,",",Dahl,N,(,2011,),Isolated,oligodontia,associated,with,mutations,in,EDARADD,",",AXlN2,",",MSX1,",",and,PAX9,genes,.}	{"x. PubMed : 16918677 .","11 ."}	{"Am J Med Genet A 155A : 1616-1622 .","PubMed : 21626677 ."}	0.75	0.954	1	{INV_DEP_PATH_POS_[nn-prep_in|NNS-prep_with|NNS-partmod|VBN@],INV_DEP_PATH_[nn-prep_in|gene-prep_with|mutation-partmod|associate@],INV_VERB_DEP_PATH_POS_[associate]_[nn-prep_in|NNS-prep_with|NNS@]_[@partmod],"INV_POS_SEQ_[VBN_IN_NNS_IN_NNP_,_NN_,_NN_,_CC]",INV_VERB_DEP_PATH_[associate]_[nn-prep_in|gene-prep_with|mutation@]_[@partmod],"INV_WORD_SEQ_[associate with mutation in EDARADD , axln2 , msx1 , and]","INV_WORD_SEQ_NER_[associate with mutation in LOCATION , axln2 , msx1 , and]"}	{0.198501,0.198501,0.198501,0.198501,0.198501,0,0}
journal.pone.0001043.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0001043.pdf_185_185_32_32_21_21	PCSK9/HP:0003124|Hypercholesterolemia	{32}	{21}	{Naoumova,RP,",",Tosi,I,",",Patel,D,",",Neuwirth,C,",",Horswell,SD,",",et,al.,(,2005,),Severe,hypercholesterolemia,in,four,British,families,with,the,D374Y,mutation,in,the,PCSK9,gene,:,long,~,term,follow-up,and,treatment,response,.}	{"J l \\\\ ’ Ied Genet .","l2 ."}	{"Arterioscler Throml ) Vasc Biol 25 : 2654 ~ 2660 .","October 2007 | Issue 10 | e1043"}	0.778	0.746	1	{"INV_WORD_SEQ_NER_[in NUMBER MISC family with the d374y mutation in the]",INV_POS_SEQ_[IN_CD_JJ_NNS_IN_DT_NN_NN_IN_DT],"INV_WORD_SEQ_[in four british family with the d374y mutation in the]",INV_DEP_PATH_POS_[nn-prep_in|NN-prep_with|NN@dobj],INV_DEP_PATH_[nn-prep_in|gene-prep_with|mutation@dobj]}	{0.42605,0.42605,0.42605,0.292762,-0.111932}
journal.pone.0089410.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0089410.pdf_249_249_38_38_28_28	SCA1/HP:0001251|Ataxia	{38}	{28}	{Burk,K,",",Abele,1,"\\\\",’,I,",",Fetter,IVI,",",Dichgans,J,",",Skalej,IVI,",",et,al.,(,1996,),Autosomal,dominant,cerel,),ellar,ataxia,type,I,clinical,features,and,IVIRI,in,families,with,SCA1,",",SCA2,and,SCA3,.}	{"Neuroreport 14 : 1799 — 1802 .","5 ."}	{"Brain 119 ( Pt 5 ) : 1497 — 1505 .","6 ."}	0.76	0.31	1	{INV_DEP_PATH_POS_[prep_with@nn-dep|NN-dobj|NN],INV_DEP_PATH_[prep_with@nn-dep|type-dobj|autosomal],INV_POS_SEQ_[NN_CD_JJ_NNS_CC_NNP_IN_NNS_IN],"INV_WORD_SEQ_[type i clinical feature and IVIRI in family with]","INV_WORD_SEQ_NER_[type NUMBER clinical feature and IVIRI in family with]"}	{0.504297,0.504297,0.170849,0,0}
journal.pone.0009234.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0009234.pdf_461_461_22_22_34_35	alpha-synuclein/HP:0100315|Lewy bodies	{22}	{34,35}	{Baba,NI,",",Nakajo,S,",",Tu,PH,",",Tomita,T,",",Nakaya,K,",",et,al.,(,1998,),Aggregation,of,alpha-synuclein,in,Lewy,bodies,of,sporadic,Parkinson,’s,disease,and,dementia,with,Lewy,bodies,.}	{"J Neuropathol Exp Neurol 55 : 259 — 272 .","6 ."}	{"Am ] Pathol 152 : 879 — 884 .","7 ."}	0.768	0.108	1	{DEP_PATH_POS_[prep_of-dobj|NN@prep_with],DEP_PATH_[prep_of-dobj|aggregation@prep_with],"WORD_SEQ_[in Lewy body of sporadic Parkinson ’s disease and dementia with]",POS_SEQ_[IN_NNP_NNS_IN_JJ_NNP_POS_NN_CC_NN_IN],"WORD_SEQ_NER_[in PERSON body of sporadic Parkinson ’s disease and dementia with]"}	{0.425083,0.220773,0.220773,0.220773,0.220773}
journal.pmed.0030156.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pmed.0030156.pdf_290_290_20_20_42_42	SDHB/HP:0002666|Pheochromocytoma	{20}	{42}	{Since,then,",",the,role,of,mitochondria,in,cancer,is,further,highlighted,through,identiﬁcation,of,over,100,mutations,in,the,SDHB,",",SDH,C,",",and,SDHD,subunit,genes,in,hundreds,of,index,cases,and,families,with,hereditary,and,sporadic,paragangliomas,and,pheochromocytomas,[,3,],.}	{"March 2006 | Vo | ume3 | | ssue3 | e167 | e156","The causal link between mitochondrial abnormalities and tumorigenesis was provided by the positional cloning of the hereditary paraganglioma gene at chromosome band llq23 as the SDHD subunit gene of mitochondrial complex II ( succinate dehydrogenase ) in the year 2000 [ 2 ] ."}	{"Furthermore , fumarase gene mutations in a distinct hereditary tumor syndrome characterized by multiple skin and uterine leiomyomatosis and renal cell cancer — hereditary leiomyomatosis renal cancer ( HLRCC ) .","— ."}	0.76	0.228	1	{WORD_SEQ_[TOO_FAR_AWAY],VERB_DEP_PATH_POS_[highlight]_[prep_in-prep_of|NNS-prep_through|NN@]_[prep_with@],VERB_DEP_PATH_[be]_[prep_in-prep_of|mutation-prep_through|identiﬁcation@auxpass]_[prep_with@auxpass],DEP_PATH_POS_[prep_in-prep_of|NNS-prep_through|NN@prep_with],DEP_PATH_[prep_in-prep_of|mutation-prep_through|identiﬁcation@prep_with],VERB_DEP_PATH_POS_[be]_[prep_in-prep_of|NNS-prep_through|NN@auxpass]_[prep_with@auxpass],VERB_DEP_PATH_[highlight]_[prep_in-prep_of|mutation-prep_through|identiﬁcation@]_[prep_with@]}	{-2.70289,0.655047,0.655047,0.655047,0.655047,0.655047,0.655047}
journal.pone.0100576.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0100576.pdf_594_594_35_35_31_31	PAX6/HP:0000526|Aniridia	{35}	{31}	{Bamiou,DE,",",Campbell,NG,",",lVIusiek,FE,",",Taylor,R,",",Chong,VVK,",",et,al.,(,2007,),Auditory,and,verbal,working,memory,deﬁcits,in,a,child,with,congenital,aniridia,due,to,a,PAX6,mutation,.}	{"Nlaekawa IVI , Iwayama Y , N akamura K , Sato l \\\\ ’ I , Toyota T , et al. ( 2009 ) A novel missense mutation ( Leu46Val ) of PAX6 found in an autistic patient .","Neurosci Lett 462 : 267 — 271 ."}	{"IntJ Audiol 46 : 1964202 .","Baba K , Okada K , Kinoshita T , Imaoka S ( 2009 ) Bisphenol A disrupts Notch signaling by inhibiting gamma-secretase activity and causes eye dysplasia of Xenopus laevis ."}	0.794	0.494	1	{INV_DEP_PATH_[nn-prep_due_to|mutation@],INV_DEP_PATH_POS_[nn-prep_due_to|NN@],INV_POS_SEQ_[JJ_TO_DT],"INV_WORD_SEQ_[due to a]",INV_VERB_DEP_PATH_POS_[work]_[nn-prep_due_to|NN-prep_with|NN-prep_in|NN@]_[prep_with-prep_in|NN@],INV_VERB_DEP_PATH_[work]_[nn-prep_due_to|mutation-prep_with|aniridium-prep_in|child@]_[prep_with-prep_in|child@]}	{0.719733,0.41231,0.137507,0.0743464,0,0}
SCPDFS_27187.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_27187.pdf_530_530_21_21_18_18	EPM1/HP:0001336|Myoclonus	{21}	{18}	{The,gene,for,human,U2,snRNP,auxiliary,factor,small,35-KDa,subunit,(,UZAFI,),maps,to,the,progressive,myoclonus,epilepsy,(,EPM1,),critical,region,on,chromosome,21q22,.3,.}	{"65 , 367 — 409 .","Lalioti , M.D. , Gos , A. , Green , M.R. , Rossier , C. , Morris , M.A. , Antonarakis , S.E. , 1996 ."}	{"Genomics 33 , 298 — 300 .","Larsson , C. , Sogseid , B. , Gberg , K. , Nakamura , Y. , Nordenskjold , M. , 1988 ."}	0.766	0.008	0.984	{"INV_WORD_SEQ_[epilepsy (]",INV_POS_SEQ_[NN_NN],INV_DEP_PATH_POS_[nn@nn],INV_DEP_PATH_[nn@nn]}	{2.18196,-1.2451,0.0460219,0.0304127}
journal.pone.0033396.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0033396.pdf_429_429_22_22_26_26	PTEN/HP:0002861|Melanoma	{22}	{26}	{Zhou,XP,",",Gimm,O,",",Hampel,H,",",Niemann,T,",",VVa1ker,IVI,],",",et,al.,(,2000,),Epigenetic,PTEN,silencing,in,malignant,melanomas,without,PTEN,mutation,.}	{"Naggar AK , Tang X , et al. ( 2001 ) Loss of PTEN expression as a prognostic marker for tongue cancer .","Arch Otolaryngol Head Neck Surg 127 : 144141445 ."}	{"Am ] Pathol 1.57 : 112341128 .","Tsutsui S , Inoue H , Yasuda K , Suzuki K , Higashi H , et al. ( 2005 ) Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast ."}	0.738	0.878	1	{DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],POS_SEQ_[NN_IN_JJ],"WORD_SEQ_[silencing in malignant]"}	{0.374951,0.356655,0.199886,0}
SCPDFS_39277.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_39277.pdf_266_266_11_11_4_5	RP11/HP:0000510|Retinitis pigmentosa	{11}	{4,5}	{Evidence,for,a,major,retinitis,pigmentosa,locus,on,19q13,.4,(,RP11,),and,association,with,a,unique,bimodal,expressivity,phenotype,.}	{"24 : 9-13 .","Al-Maghtheh , M. , Vithana , E. , Tarttelin , E. , Jay , M. , Evans , K. , Moore , T. , Bhattacharya , S. , and Inglehearn , C. F. ( 1996 ) ."}	{"Am .","J. Hum ."}	0.71	0.006	0.99	{INV_POS_SEQ_[NN_IN_NN_CD_CD],INV_DEP_PATH_POS_[nn-dep|NN@nn-prep_for|NN],"INV_WORD_SEQ_NER_[locus on 19q13 NUMBER NUMBER]","INV_WORD_SEQ_[locus on 19q13 .4 (]",INV_DEP_PATH_[nn-dep|)@nn-prep_for|locus]}	{0.521439,-0.377656,0.365757,0.365757,0}
SCPDFS_46861.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_46861.pdf_297_297_12_12_26_28	DNAH11/HP:0001696|Situs inversus totalis	{12}	{26,27,28}	{18,Bartoloni,",",L.,et,al.,(,2002,),Mutations,in,the,DNAH11,(,axonemal,heavy,chain,dynein,type,11,),gene,cause,one,form,of,situs,inversus,totalis,and,most,likely,primary,ciliary,dyskinesia,.}	{"Genet .","30 , 143-144"}	{"Proc .","Natl. Acad ."}	0.778	0.042	0.984	{"WORD_SEQ_[( axonemal heavy chain dynein type 11 ) gene cause one form of]",POS_SEQ_[NN_JJ_JJ_NN_NN_NN_CD_NN_NN_NN_CD_NN_IN],"WORD_SEQ_NER_[( axonemal heavy chain dynein type NUMBER ) gene cause NUMBER form of]",DEP_PATH_[nn-prep_in|(-dep|(-dep|L.@prep_of-dep|form],DEP_PATH_POS_[nn-prep_in|NN-dep|FW-dep|NNP@prep_of-dep|NN]}	{0.398904,0.398904,0.398904,0,0}
SCPDFS_20186.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_20186.pdf_205_205_17_17_20_22	CYP11B1/HP:0008258|Congenital adrenal hyperplasia	{17}	{20,21,22}	{Analyzing,the,functional,and,structural,consequences,of,two,point,mutations,(,P94L,and,A368D,),in,the,CYP11B1,gene,causing,congenital,adrenal,hyperplasia,resulting,from,11,—,hydroxylase,deﬁciency,.}	{"17 , 85-107 .","Krone , N. , et al. , 2006 ."}	{"J. Clin .","Endocrinol ."}	0.704	0.282	1	{DEP_PATH_POS_[nn@dobj-partmod|VBG],POS_SEQ_[NN_VBG],"WORD_SEQ_[gene cause]",VERB_DEP_PATH_POS_[cause]_[nn@partmod]_[dobj@],DEP_PATH_[nn@dobj-partmod|cause],VERB_DEP_PATH_[cause]_[nn@partmod]_[dobj@],VERB_DEP_PATH_POS_[analyze]_[nn-prep_in|NN-dep|VBP@]_[dobj-partmod|VBG-prep_in|NN-dep|VBP@],VERB_DEP_PATH_[analyze]_[nn-prep_in|gene-dep|(@]_[dobj-partmod|cause-prep_in|gene-dep|(@],VERB_DEP_PATH_[result]_[nn@partmod-dobj|hyperplasium-partmod|cause]_[@partmod],VERB_DEP_PATH_POS_[result]_[nn@partmod-dobj|NN-partmod|VBG]_[@partmod]}	{-1.30631,-0.977476,0.879441,0.823474,0.823474,0.823474,0,0,0,0}
SCPDFS_45226.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_45226.pdf_24_24_0_0_9_9	DM/HP:0002486|Myotonia	{0}	{9}	{DM,is,an,autosomal,dominant,disease,that,results,in,myotonia,and,dystrophy,of,skeletal,muscle,",",cardiac,dysfunction,",",and,involvement,of,other,systems,(,for,review,",",see,Alberts,and,Roses,",",1989,),.}	{"All rights of reproduction in any form reserved .","muscular dystrophy ( DM ) ."}	{"Since the biochemical basis of DM is unknown , linkage methods have been used to identify molecular probes that are tightly linked to the disease gene .","DM was initially localized to human chromosome 19 by linkage to several blood group and serum markers ( Renwick et al. , 1971 ; Eiberg et al. , 1981 ; Whitehead et al. , 1982 ) ."}	0.756	0.008	1	{DEP_PATH_[nsubj@prep_in-rcmod|result],VERB_DEP_PATH_[result]_[nsubj@rcmod]_[prep_in@],VERB_DEP_PATH_[be]_[nsubj@cop]_[prep_in-rcmod|result@cop],VERB_DEP_PATH_POS_[result]_[nsubj@rcmod]_[prep_in@],VERB_DEP_PATH_POS_[be]_[nsubj@cop]_[prep_in-rcmod|VBZ@cop],DEP_PATH_POS_[nsubj@prep_in-rcmod|VBZ],"WORD_SEQ_[be a autosomal dominant disease that result in]",VERB_DEP_PATH_POS_[see]_[nsubj@ccomp-rcmod|VBZ]_[prep_in@ccomp],VERB_DEP_PATH_[see]_[nsubj@ccomp-rcmod|result]_[prep_in@ccomp],POS_SEQ_[VBZ_DT_JJ_JJ_NN_WDT_VBZ_IN]}	{0.186349,0.186349,0.186349,0.186349,0.186349,0.186349,0,0,0,0}
SCPDFS_43354.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_43354.pdf_317_317_9_9_16_17	COL2A1/HP:0002655|Spondyloepiphyseal dysplasia	{9}	{16,17}	{Tandem,duplication,within,a,type,II,collagen,gene,(,COL2A1,),exon,in,an,individual,with,spondyloepiphyseal,dysplasia,.}	{"7 76-779 , Year Book Medical Publishers , Chicago .","Tiller , G. E. , Rimoin , D. L. , Murray , L. W. , and Cohn , D. H. ( 1990 ) ."}	{"Proc .","Natl. Acad ."}	0.73	0.004	1	{DEP_PATH_POS_[dep-dep|NN@prep_with-prep_in|JJ-dep|NN],"WORD_SEQ_NER_[NUMBER exon in a individual with]","WORD_SEQ_[) exon in a individual with]",DEP_PATH_[dep-dep|gene@prep_with-prep_in|individual-dep|exon],POS_SEQ_[CD_NN_IN_DT_JJ_IN]}	{0.217823,0.217823,0.217823,0.217823,0.217823}
